The European chemical industry is key to economic development and wealth. It creates modern products and materials, and provides virtually all sectors of the economy with technical solutions. The European chemical industry supplies virtually all sectors of the economy and accounts for 17.8% of the total sales of chemicals in the world. It is one of the largest and most R&D-intensive manufacturing sectors in all the advanced economies, and its innovative patterns and productivity growth processes can have profound impacts on economic growth as a whole. In a recent study, Tullo shows that 19 of the top 50 global chemical companies are headquartered in Europe and they make 14.5% of all sales of chemicals in the world. The purpose of this book is to provide an overview of the status of the European chemical industry and the problems it currently faces. According to specialists, innovation and research are key to securing the future of the European chemical industry. Research and development is one way in which companies can ensure future growth by developing new products or processes to improve and expand their operations. The book discusses investment in research and development in the European chemical industry in general and also in the top fifteen European chemical companies in particular. In order to understand research strategy and trends in innovation, we analyze R&D investment, the patent landscape, university-industry collaboration and the regional distribution of chemical companies.

Innovation underpins competitiveness, is crucial to addressing societal challenges, and its support has become a major public policy goal. But what really works in innovation policy, and why? This Handbook, compiled by leading experts in the field, is the first comprehensive guide to understanding the logic and effects of innovation polices. The Handbook develops a conceptualisation and typology of innovation policies, presents meta-evaluations for 16 key innovation policy instruments and analyses evidence on policy-mix. For each policy instrument, underlying rationales and examples are presented, along with a critical analysis of the available impact evidence. Providing access to primary sources of impact analysis, the book offers an insightful assessment of innovation policy practice and its evaluation.

R&D, Innovation and Competitiveness in the European Chemical Industry explores the science & technology base and the dynamic performance of the European "system of innovation" in the chemical industry, with particular attention to its contribution to economic growth through innovation and competitiveness, and its ability to translate its research into commercially useful products. It also analyses the forces that encourage the diffusion of chemical innovations on downstream user industries and among large and small firms. The studies presented in this book represent an analysis of the issues and questions raised by the Green Paper on Innovation presented by the European Commission, for the specific case of the European chemical industry. R&D, Innovation and Competitiveness in the European Chemical Industry will be of interest to industry and government experts related to the chemical industry, scholars; both faculty and graduate students interested in growth, corporate strategy and the management of innovation.

This volume provides a novel way of examining innovation in sectors by proposing the framework of sectoral systems of innovation. It analyses the innovation process, the factors affecting innovation, the changing boundaries and transformation of sectors, and the determinants of the innovation performance of firms and countries in different sectors.

This review assesses the governance of Luxembourg’s innovation system and suggests the reforms needed to ensure that additional public investment in R&D will yield the expected economic and social benefits.

Recognizing that innovation is the key to international competitiveness in the 21st century, policymakers around the world are seeking more effective ways to translate scientific and technological knowledge into new products, processes, and businesses. They have initiated major programs, often with substantial funding, that are designed to attract, nurture, and support innovation and high-technology industries within their national economies. To help U.S. policymakers become more aware of these developments, a committee of the National Academies' Board on Science, Technology, and Economic Policy undertook a review of the goals, concept, structure, operation, funding levels, and evaluation efforts of significant innovation programs around the world. As a part of this effort, the committee identified Flanders, a region of Belgium with substantial autonomy, which is recognized for its comprehensive approach to innovation. Based on initial meetings in Washington and Brussels, and with the endorsement of Flanders Vice Minister-President Fientje Moerman, it was agreed to organize a conference that would review regional innovation policies in the context of the policies and programs of the Flanders government, and their interaction with those of the European Union. This book provides a summary of that symposium.

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.